Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser
A
A
Department of Hematology and Oncology, Hannover Medical School, Germany.
Hoelzer
D
D
D003561:Cytarabine / Q000627:therapeutic use; D004921:Erythropoietin / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D007377:Interleukin-3 / Q000627:therapeutic use; D009190:Myelodysplastic Syndromes / Q000628:therapy*
D016298:Hematopoietic Cell Growth Factors; D007377:Interleukin-3; D003561:Cytarabine; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor